KingsCrowd, one of the leading platforms for private market investment research and deal analysis, recently hosted a conversation between KingsCrowd CEO Chris Lustrino and Zeus Companies founder Dr. Steven Kaufman, whom many in the industry consider one of the more credible and experienced voices in the private credit and real estate debt space.
A QUARTER CENTURY OF UNINTERRUPTED PERFORMANCE
At the center of the conversation was a track record that is rare in any asset class: Zeus Companies, a Houston-based private equity firm with approximately $1 billion in assets under management, has paid monthly distributions to investors without interruption for nearly 25 years. That streak includes the dot-com collapse, the 2008 subprime mortgage crisis, the COVID-19 pandemic, and the supply chain disruptions that followed.
Dr. Kaufman noted that the consistency of monthly distributions is by design, not accident. Unlike funds that pay quarterly or hold distributions at management’s discretion, Zeus structures its note investments so that investor payments are directly tied to borrower repayments on collateralized real estate, creating a transparent and predictable income stream.
“Investors get to keep their hand on the pulse of how well our company is doing,” Dr. Kaufman explained during the webinar, “versus waiting a quarter to be told, ‘Well, we’re not doing distributions this quarter.'”
The result: 94% of investors who have ever committed capital to Zeus Companies continue to invest with the firm today.
PRECISION UNDERWRITING: $12,000 OFF ON A $14 MILLION EXIT
Perhaps the most striking moment of the webinar came when Dr. Kaufman disclosed the final results on a recently exited equity development project, a mixed-use medical and retail asset in Houston’s Heights neighborhood that Zeus Companies originated in 2018 and exited in March 2026.
The project, valued at approximately $14 million at exit, came in within $12,000 of the original pro forma projection, a variance of less than one-tenth of one percent, achieved after navigating COVID-related construction halts, an eviction moratorium, and prolonged supply chain disruptions.
The firm also exceeded its revenue pro forma for the project by 27%, meaning investors received significantly stronger distributions throughout the hold period while the exit price itself tracked almost exactly to original underwriting.
“We did the pro forma in 2018. We broke ground in 2019. Six years later, on a $14 million project, we missed the pro forma by $12,000. One-tenth of 1%.”
— Dr. Steven Kaufman, Zeus Companies
Dr. Kaufman attributed this level of precision to Zeus’s foundational identity as a lender:
“We look at a deal first as a lender. Would we lend on this deal? If we would, then let’s look at it as an investment.”
THE DEBT PLATFORM: COLLATERALIZED, MONTHLY INCOME AT 8-12%
Zeus Companies operates a real estate note investment platform through its affiliated lending company, ZeusLending.com, which originates fix-and-flip and landlord loans primarily in the Texas market. Investors, both individual and institutional, can participate in individual notes or pooled fund vehicles, earning between 8% and 12% annually, paid monthly.
“8%-12% rates may not make you wealthy, but it will keep you wealthy. And that’s why our investors count on us.”
— Dr. Steven Kaufman, Founder, Zeus Companies
Key structural features discussed during the webinar include:
- First-lien collateral assignment on all note investments, providing investors direct lien protection independent of Zeus Companies
- An average loan-to-value ratio of 63%, providing substantial equity cushion against loss
- 1099 tax reporting (not K-1), enabling clean and fast year-end filing
- Liquidity provisions including a 2% early exit fee structure for investors needing access to capital before a note matures
- Compatibility with self-directed IRAs, Roth IRAs, family limited partnerships, and trust structures
Zeus also maintains an intentionally small investor base, with fewer than 100 investors across a $100 million debt portfolio, averaging approximately $400,000 per relationship. Institutional capital from a New York-based firm, as well as investors from Canada, China, Israel, and Mexico, round out the capital base.
PROPRIETARY UNDERWRITING INSIGHTS FROM 17,000 TRANSACTIONS
Dr. Kaufman revealed that Zeus Companies recently applied artificial intelligence to analyze the full dataset of its 17,000 lending transactions, looking for patterns in borrower performance, investor outcomes, and predictors of loan success or failure.
The findings challenged conventional lending wisdom. Neither credit score nor loan-to-value ratio proved to be the primary predictor of borrower performance. Instead, the analysis identified other variables as more meaningful, insights that Dr. Kaufman noted have been incorporated into Zeus’s current underwriting framework but were not fully disclosed on the webinar.
“When you do something 17,000 times, you learn a lot,” Dr. Kaufman said. “And thanks to AI, we’re really able to analyze what has gone wrong and what has gone right, and true up our process with a lot more precision.”
HEALTHCARE EQUITY: THE OTHER HALF OF THE ZEUS PORTFOLIO
Beyond its debt platform, Zeus Companies invests in healthcare real estate on the equity side, specializing in medical office buildings (MOBs), ambulatory surgical centers (ASCs), hospital outpatient departments (HOPDs), and what it calls “med-tail” developments: retail properties anchored by strong medical tenants.
Zeus’s average equity transaction is approximately $15 to $20 million, with the firm completing one to two new investments per year. Rather than raising fund capital in advance, Zeus invests its own capital first and then extends participation opportunities to a select group of co-investors. In all but two of its historical equity transactions, Zeus has been the largest investor in the deal.
A particularly distinctive feature of Zeus’s healthcare strategy: the firm often negotiates a minority interest in the operating healthcare company itself, not just the real estate. Dr. Kaufman explained that this approach ties the real estate and business interests together, giving Zeus alignment with the long-term success of its tenants.
Zeus holds its equity investments for three to seven years, targeting IRRs that have historically exceeded 16% on exited transactions across more than 25 years of operations.
THE TEXAS THESIS: STABLE APPRECIATION IN THE COUNTRY’S FASTEST-GROWING ECONOMIC ENGINE
Throughout the webinar, Dr. Kaufman made a confident case for Texas as the defining investment geography of the next decade. He cited the Houston Ship Channel as the top port in the United States by import and export volume, surpassing the combined output of the Los Angeles, New York, and Louisiana ports. He projected that migration into Houston alone will add more residents by 2030 than currently live in the entire city of Austin.
“When you look at Austin, Dallas, and Houston combined, our economic output over the next 10 years will be the greatest of any other state in the country, more than California and more than New York,” Dr. Kaufman stated.
Zeus’s investment philosophy treats Texas real estate’s steady 3.5% to 7% annual appreciation not as a weakness but as the feature, a predictable, dynastic asset for families focused on preserving wealth across generations rather than chasing short-cycle returns.
“We may walk slowly, but we never walk back.”
— Abraham Lincoln, as cited by Dr. Kaufman on the parallels between the Lincoln philosophy and Texas real estate
Dr. Steven Kaufman serves as Founder and CEO of Zeus Companies, where his leadership in finance and real estate development has contributed significantly to Houston’s economic landscape. His innovative approaches to business development and financial strategy have earned recognition from both peers and public officials.
Learn more about Zeus Companies at https://zeuscompanies.com